IMPURITIES AVAILABLE FOR 'Selexipag'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Selexipag. Selexipag is an oral selective prostacyclin receptor (IP receptor) agonist used in the treatment of pulmonary arterial hypertension (PAH). It works by relaxing pulmonary blood vessels, reducing vascular resistance, and improving blood flow, thereby lowering the strain on the heart. Unlike traditional prostacyclin analogs, Selexipag is a non-prostanoid compound, offering greater stability and receptor selectivity. It helps delay disease progression and reduces the risk of hospitalization in PAH patients. The drug is usually prescribed as part of combination therapy with other PAH medications such as endothelin receptor antagonists or phosphodiesterase-5 inhibitors. Selexipag is administered orally, providing a more convenient alternative to injectable prostacyclin therapies. Common side effects include headache, flushing, diarrhea, nausea, and jaw pain due to vasodilatory effects. Careful dose titration is required to achieve optimal efficacy while minimizing adverse reactions. Buy high quality Selexipag from Omsynth Lifesciences.